A proposed staging for children with neuroblastoma. Children's cancer study group A

No abstract is available for this paper.

• Publication year

  1971

• Venue

  Cancer

• Publication date

  1971-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO;2-GPMID 5100400
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroblastoma in childhood.

  1969cited by this paper
• Vincristine sulfate and cyclophosphamide for children with metastatic neuroblastoma.

  1969cited by this paper
• Observations on the histopathology of neuroblastomas.

  1968cited by this paper
• Survival of children with neuroblastoma treated with combination chemotherapy.

  1968cited by this paper
• Treatment of malignant sympathetic tumors in children: clinicopathological correlation.

  1968cited by this paper
• Urinary catecholamine excretion by healthy children. I. Daily excretion of dopamine, norepinephrine, epinephrine, and 3-methoxy-4-hydroxymandelic acid.

  1967cited by this paper
• Neuroblastoma in childhood

  1966cited by this paper
• American joint committee on cancer staging and end results reporting. Objectives and progress

  1965cited by this paper
• IN SITU NEUROBLASTOMAS: A CONTRIBUTION TO THE NATURAL HISTORY OF NEURAL CREST TUMORS.

  1963cited by this paper
• Neuroblastoma sympatheticum; a study and report of 217 cases.

  1959cited by this paper
• Neuroblastoma in childhood; survival after major surgical insult to the tumor.

  1955cited by this paper
• The Transformation of a Malignant Paravertebral Sympathicoblastoma into a Benign Ganglioneuroma.

  1927cited by this paper

• Emerging clinical and research approaches in targeted therapies for high-risk neuroblastoma

  2025cites this paper
• Trajectory analysis reveals an uncommitted neuroblastic state in MYCN-driven neuroblastoma development

  2025cites this paper
• Primary Hepatic Neuroblastoma in a 5.5-Month-Old Boy: A Case Report

  2024cites this paper
• Role of surgery in neuroblastoma

  2023cites this paper
• Identification of genes associated with spontaneous regression of neuroblastoma

  2023cites this paper
• Maintaining excellent outcomes: the impact of age cutoff reclassification on reduced therapy for neuroblastoma patients

  2023cites this paper
• The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics

  2023cites this paper
• The development of stratification and segregation in a new scientific field: A study of collaboration among scientists in neuroblastoma research between 1975 and 2016

  2023cites this paper
• Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease

  2023cites this paper
• Opsoclonus‐myoclonus syndrome associated with neuroblastoma: Insights into antitumor immunity

  2022cites this paper
• Advances in the treatment of pediatric solid tumors: A 50‐year perspective

  2022cites this paper
• Neuroblastoma: Essential genetic pathways and current therapeutic options.

  2022cites this paper
• Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

  2022cites this paper
• Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children

  2022cites this paper
• WANTED: Better neuroblastoma biomarkers and better stratification

  2022cites this paper
• Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4

  2022cites this paper
• Foreword to special issue on radiation oncology

  2021cites this paper
• A strike against indolent neuroblastoma

  2020cites this paper
• The Over-Expression of E2F3 Might Serve as Prognostic Marker for Neuroblastoma Patients with Stage 4S Disease

  2020cites this paper
• Combined analysis of RNA‐sequence and microarray data reveals effective metabolism‐based prognostic signature for neuroblastoma

  2020cites this paper
• Pediatric Solid Tumors

  2020cites this paper
• Combinatorial treatment of curcumin or silibinin with doxorubicin sensitises high-risk neuroblastoma

  2020cites this paper
• Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma

  2020cites this paper
• Spontaneous regression of stage III neuroblastoma: A case report

  2020cites this paper
• Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis

  2020cites this paper
• Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future.

  2020cites this paper
• Adrenal Glands

  2020cites this paper
• CDGSH Iron Sulfur Domain 2 Deficiency Inhibits Cell Proliferation and Induces Cell Differentiation of Neuroblastoma

  2019cites this paper
• High-Risk Neuroblastoma and Current Protocols

  2019cites this paper
• Image-Defined Risk Factors

  2019cites this paper
• Targeting Angiogenesis in Neuroblastoma

  2019cites this paper
• Neuroblastoma—A Neural Crest Derived Embryonal Malignancy

  2019cites this paper
• Neurogenic Tumors

  2019cites this paper
• The Evolution of Risk Classification for Neuroblastoma

  2019cites this paper
• Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease

  2019cites this paper
• Subgrouping of Unfavorable Histology Neuroblastomas With Immunohistochemistry Toward Precision Prognosis and Therapy Stratification.

  2019cites this paper
• Neonatal Neuroblastoma with Pepper Syndrome: A Case Report

  2019cites this paper
• Hypoxia and Stem Cells in Normal and Tumor Development

  2019cites this paper
• Synthesis, characterization and biological applications of selenoureas having ferrocene and substituted benzoyl functionalities

  2019cites this paper
• Spontaneous regression of neuroblastoma

  2018influential citation
• On the Diagnostics of Neuroblastoma

  2018cites this paper
• Proceedings INNODOCT/18. International Conference on Innovation, Documentation and Education

  2018cites this paper
• Neonatal neuroblastoma 4s with diffuse liver metastases (Pepper syndrome) without an adrenal/extraadrenal primary identified on imaging.

  2018cites this paper
• Neuroblastoma

  2018cites this paper
• Origin and initiation mechanisms of neuroblastoma

  2018cites this paper
• Diseño de Interfaz para herramienta para la medición semicuantitativa de imágenes de gammagrafía de 123-I-mIBG

  2018cites this paper
• INVESTIGATING THE EFFECT OF 1,25-DIHYDROXYVITAMIN D3 AND RETINOIC ACID ON VIABILITY, DIFFERENTIATION AND MIGRATION IN NB69 AND T47D CELLS

  2018cites this paper
• Novel therapeutic targets in pediatric neural tumors

  2018cites this paper
• Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma

  2018cites this paper
• Validation of pre-analytical parameters to introduce cell-free tumor DNA as reliable minimal-invasive diagnostic tool

  2017cites this paper
• Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979–2015

  2017cites this paper
• Clinical evaluation of integrated panel testing by next-generation sequencing for somatic mutations in neuroblastomas with MYCN unamplification

  2017cites this paper
• A multiobjective deep learning approach for predictive classification in Neuroblastoma

  2017cites this paper
• Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors

  2017cites this paper
• Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.

  2017cites this paper
• Oncogenic ALK signaling in neuroblastoma

  2017cites this paper
• Retinoic Acid for High-risk Neuroblastoma Patients after Autologous Stem Cell Transplantation – Cochrane Review

  2016cites this paper
• The Role of N1-Src in Neuronal Development

  2016cites this paper
• Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait

  2016cites this paper
• Neuroblastoma and Other Adrenal Tumors

  2016cites this paper
• The Role of Stromal-Derived Factors in Neuroblastoma Differentiation

  2016cites this paper
• Genomic Analysis of Bone Marrow-Derived Disseminated Neuroblastoma Cells

  2016cites this paper
• Trends in incidence of childhood malignant solid tumors in Japan: Estimation based on hospital-based registration.

  2015cites this paper
• INHIBITION MYCN- VERMITTELTER ZELLZYKLUSTRANSITION DURCH THYROID CANCER 1 (TC1) IM NEUROBLASTOM – ETABLIERUNG UND CHARAKTERISIERUNG DES TC1- ÜBEREXPRESSIONSPHÄNOTYPS IN HUMANEN SH-EP NEUROBLASTOMZELLEN UNTER DEM EINFLUSS VON MYCN

  2015cites this paper
• Endoglin (CD 105) as a potential prognostic factor in neuroblastoma

  2015cites this paper
• Risk Estimation and Treatment Strati fi cation of Low-and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

  2015cites this paper
• Neuroblastoma en niños menores de 18 meses. Experiencia de 10 años en el Centro Hematooncológico Pediátrico del Centro Hospitalario Pereira Rossell

  2015cites this paper
• Neuroblastoma en niños menores de 18 meses. Experiencia de 10 años en Centro Hematooncológico

  2015cites this paper
• Ferrocene incorporated selenoureas as anticancer agents.

  2015cites this paper
• High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.

  2015cites this paper
• Stem cell transplantation in Iran: a systematic review article.

  2015cites this paper
• Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation.

  2015cites this paper
• Downregulation of MYCN oncogene by retinoic acid in neuroblastoma

  2014cites this paper
• Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

  2014cites this paper
• Evaluation of the combined treatment with cisplatin and melatonin on neuroblastoma cell viability and antioxidant capacity

  2014cites this paper
• Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.

  2014cites this paper
• Mechanisms of neuroblastoma regression

  2014cites this paper
• Optional Proposals for Testing New Telescopic Ramifications of TNM

  2014cites this paper
• Effectiveness of Nationwide Screening Program for Neuroblastoma in Japan

  2014cites this paper
• Survival of children with neuroblastoma treated at the Institute of oncology in Ljubljana in two periods

  2014cites this paper
• Significance and Therapeutic Value of miRNAs in Embryonal Neural Tumors

  2014cites this paper
• Neuroblastome entstehen aus Neuralleistenstammzellen

  2014influential citation
• Age-Dependent Prognostic Effect by Mitosis-Karyorrhexis Index in Neuroblastoma: A Report from the Children's Oncology Group

  2014cites this paper
• Evaluación de una puntuación semicuantitativa de MIBG como factor pronóstico en neuroblastoma metastásico y correlación con otros factores pronósticos conocidos

  2013cites this paper
• High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.

  2013cites this paper
• Ekspresija čimbenika stanične smrti u neuroblastomu

  2013cites this paper
• Emerging drugs for neuroblastoma

  2013cites this paper
• Coping With Pediatric Cancer: Conversational Methods Utilized by Parents and Children when Dealing with Pediatric Cancer

  2013cites this paper
• Disseminated Fusariosis Secondary to Neuroblastoma with Fatal Outcome

  2013cites this paper
• Update on Pediatric Opsoclonus Myoclonus Syndrome

  2013cites this paper
• Peripheral neuroblastic tumors with genotype–phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee

  2013cites this paper
• Ten challenges in the management of neuroblastoma.

  2012cites this paper
• Pediatric urologic oncology.

  2012cites this paper
• Recurrent Neuroblastoma

  2012cites this paper
• Impact of N-myc Amplification on Median Survival in Children With Neuroblastoma

  2012cites this paper
• Chapter 80 – Congenital Malignant Disorders

  2012cites this paper
• Estado del arte: tumores de cresta neural, neuroblastoma fisiopatología, diagnóstico y tratamiento

  2012cites this paper
• YB-1: Functional Analysis of a Potential Serum Marker for Neuroblastoma

  2012cites this paper
• Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent?

  2012cites this paper
• The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma

  2012cites this paper